ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 137765 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 137765; 2) Community: the network communities that were significantly associated with the response to NSC 137765; 3) Molecule: the relationships between components within communities and NSC 137765; 4) MDR: the compounds that were significantly associated with the NSC 137765.

NSC Compound Enrichment Correlation
NSC 87500 Solacongestidine 0.0284045326811618 0.21678854
NSC 107043 Null 0.0286383688883668 0.18081908
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0286383688883668 0.24172058
NSC 149765 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) 0.0286383688883668 -0.073324761
NSC 251677 10-Desacetylbaccatin III 0.0286383688883668 0.47640295
NSC 31780 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) 0.0286383688883668 0.33735361
NSC 346098 Null 0.0286383688883668 0.38307795
NSC 357777 Null 0.0286383688883668 0.33731636
NSC 359415 Null 0.0286383688883668 0.12291399
NSC 37432 2-Propen-1-one, 3-(2-hydroxyphenyl)-1-phenyl- (9CI) 0.0286383688883668 0.39241049
Total:149  Current:102    [First] [Prev] [Next] [Last]